Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

OTHER × Survival Without Progression × Celecoxib × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Colorectal Neoplasms 26 Breast Neoplasms 21 Carcinoma, Non-Small-Cell Lung 19 Lung Neoplasms 15 Head and Neck Neoplasms 12 Rectal Neoplasms 11 Colonic Neoplasms 11 Prostatic Neoplasms 8 Pancreatic Neoplasms 7 Mouth Neoplasms 6 Glioblastoma 6 Neuroblastoma 5 Neoplasm Metastasis 5 Esophageal Neoplasms 5 Central Nervous System Neoplasms 5 Unspecified Adult Solid Tumor, Protocol Specific 4 Triple Negative Breast Neoplasms 4 Recurrence 4 Precancerous Conditions 4 Ovarian Neoplasms 4 Neoplasms 4 Liver Neoplasms 4 Gliosarcoma 4 Carcinoma, Hepatocellular 4 Carcinoma 4 Adenomatous Polyposis Coli 4 Sarcoma 3 Oropharyngeal Neoplasms 3 Medulloblastoma 3 Laryngeal Neoplasms 3

Interventions

Vinblastine 1 Methotrexate 1 Cyclophosphamide 1 Celecoxib 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT01285817 2023-03-13

SFCE METRO 01

Assistance Publique Hopitaux De Marseille

Phase 2 Completed

Survival Without Progression

Data powered by HemOnc (CC BY 4.0) Colophon ⚡